Govt examining Pfizer's request for indemnity, will take decision on merit: VK Paul
"We are looking at what their expectations are from the government and they are looking at what our expectations are from them," V K Paul said.
Stay updated with breaking news from Post Approval Commitment. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
"We are looking at what their expectations are from the government and they are looking at what our expectations are from them," V K Paul said.
The government is examining Pfizer's request for indemnity and will take a decision in the larger interest of people and on merit, NITI Aayog Member (Health) VK Paul said today.
Seeking a fast track from the Centre, Pfizer also said that the candidate is suitable for everyone aged 12 years or above
Coronavirus News LIVE Updates: Partial Lockdown Extended in Bengal Till June 15; Sputnik V to be Available from 2nd Week of June News18 2 days ago News18 © Provided by News18 Coronavirus News LIVE Updates: Partial Lockdown Extended in Bengal Till June 15; Sputnik V to be Available from 2nd Week of June Coronavirus News LIVE Updates: Sputnik V, the third vaccine approved in India, will be available through the Apollo Hospitals from the 2nd week of June. Seeking a fast-track approval for its COVID-19 vaccine, US major Pfizer has told Indian authorities that its jab has show...
The Federal Pfizer says its vaccine effective on COVID mutant, suitable for 12+ Stating that it would roll out five crore doses by year-end, company requests indemnification to enable vaccine supply to India COMMENTS Representative photo: iStock American pharma major Pfizer has told the Centre that its COVID-19 vaccine has shown “high effectiveness” against the variant which is supposed to have triggered a second wave of infections in the country. Pfizer has said that it would roll out five crore doses of the vaccine by the year-end, informing that the shots are suitable...